| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Van de Warrenburg and Kremer) and Human Genetics (Dr. Knoers), University Medical Center St. Radboud, Nijmegen; Departments of Neurology (Dr. Brunt) and Clinical Genetics (Drs. Verschuuren–Bemelmans and Scheffer), University Hospital, Groningen; Departments of Medical Genetics (Drs. Sinke, Ippel, and Lindhout) and Neurology (Dr. Notermans), University Medical Center Utrecht; and Department of Clinical Genetics (Drs. Maat–Kievit and Dooijes), Erasmus University Medical Center, Rotterdam, the Netherlands.
Address correspondence and reprint requests to Dr. B.P.C. van de Warrenburg, University Medical Center St. Radboud, Department of Neurology, Reinier Postlaan 4, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; e-mail: b.vandewarrenburg{at}czzoneu.azn.nl
Background: International prevalence estimates of autosomal dominant cerebellar ataxias (ADCA) vary from 0.3 to 2.0 per 100,000. The prevalence of ADCA in the Netherlands is unknown. Fifteen genetic loci have been identified (SCA-1-8, SCA-10-14, SCA-16, and SCA-17) and nine of the corresponding genes have been cloned. In SCA-1, SCA2, SCA3, SCA6, SCA7, SCA-12 and SCA-17 the mutation has been shown to be an expanded CAG repeat. Previously, the length of the CAG repeat was found to account for 50 to 80% of variance in age at onset. Because of heterogeneity in encoded proteins, different pathophysiologic mechanisms leading to neurodegeneration could be involved. The relationship between CAG repeat length and age at onset would then differ accordingly.
Method: Based on the results of SCA mutation analysis in the three DNA diagnostic laboratories that serve the entire Dutch population, the authors surveyed the number of families and affected individuals per SCA gene, as well as individual repeat length and age at onset. Regression analysis was applied to study the relationship between CAG repeat length and age at onset per SCA gene. The slopes of the different regression curves were compared.
Results: On November 1, 2000, mutations were found in 145 ADCA families and 391 affected individuals were identified. The authors extrapolated a minimal prevalence of 3.0 per 100,000 (range 2.8 to 3.8/100,000). SCA3 was the most frequent mutation. CAG repeat length contributed to 52 to 76% of age at onset variance. Regression curve slopes for SCA-1, SCA2, SCA3, and SCA7 did not differ significantly.
Conclusions: The estimated minimal prevalence of ADCA in the Netherlands is 3.0 per 100,000 inhabitants. Except for SCA6, the relationship between age at onset and CAG repeat expansion does not differ significantly between SCA-1, SCA2, SCA3, and SCA7 patient groups in our population, indicating that these SCA subtypes share similar mechanisms of polyglutamine-induced neurotoxicity, despite heterogeneity in gene products.
This article has been cited by other articles:
|
|
 |
|
  S. Gupta, O. Fiertag, and J. Warner Rare and unusual dementias Adv. Psychiatr. Treat., September 1, 2009; 15(5): 364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Erichsen, J. Koht, A. Stray-Pedersen, M. Abdelnoor, and C. M. E. Tallaksen Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study Brain, June 1, 2009; 132(6): 1577 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Martins, F. Calafell, C. Gaspar, V. C. N. Wong, I. Silveira, G. A. Nicholson, E. R. Brunt, L. Tranebjaerg, G. Stevanin, M. Hsieh, et al. Asian Origin for the Worldwide-Spread Mutational Event in Machado-Joseph Disease Arch Neurol, October 1, 2007; 64(10): 1502 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Bichelmeier, T. Schmidt, J. Hubener, J. Boy, L. Ruttiger, K. Habig, S. Poths, M. Bonin, M. Knipper, W. J. Schmidt, et al. Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence J. Neurosci., July 11, 2007; 27(28): 7418 - 7428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Duenas, R. Goold, and P. Giunti Molecular pathogenesis of spinocerebellar ataxias Brain, June 1, 2006; 129(6): 1357 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Pulst, N. Santos, D. Wang, H. Yang, D. Huynh, L. Velazquez, and K. P. Figueroa Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset Brain, October 1, 2005; 128(10): 2297 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Verbeek, B. P. van de Warrenburg, P. Wesseling, P. L. Pearson, H. P. Kremer, and R. J. Sinke Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3 Brain, November 1, 2004; 127(11): 2551 - 2557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guerrini, F. Lolli, A. Ginestroni, G. Belli, R. D. Nave, C. Tessa, S. Foresti, M. Cosottini, S. Piacentini, F. Salvi, et al. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study Brain, August 1, 2004; 127(8): 1785 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. C. van de Warrenburg, N. C. Notermans, H. J. Schelhaas, N. van Alfen, R. J. Sinke, N. V. A. M. Knoers, M. J. Zwarts, and B. P. H. Kremer Peripheral Nerve Involvement in Spinocerebellar Ataxias Arch Neurol, February 1, 2004; 61(2): 257 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P.C. van de Warrenburg, D. S. Verbeek, S. J. Piersma, F. A.M. Hennekam, P. L. Pearson, N. V.A.M. Knoers, H. P.H. Kremer, and R. J. Sinke Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family Neurology, December 23, 2003; 61(12): 1760 - 1765. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
